Practical considerations when treating chronic hepatitis E in solid organ transplant recipients

被引：0

作者：

Choi, David K. ^{[1
]}

Martin, Michelle T. ^{[1
]}

Chacra, Wadih ^{[2
]}

Chan, Christine ^{[2
]}

Koppe, Sean ^{[2
]}

Landers, Lisa ^{[2
]}

Naveed, Ammara ^{[2
]}

Mikolajczyk, Adam E. ^{[2
]}

机构：

[1] Univ Illinois, Coll Pharm, 833 S Wood St,Suite 164,M-C 886, Chicago, IL 60612 USA

[2] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2021年 / 43卷 / 03期

关键词：

Hepatitis E virus; Liver transplant; Ribavirin; Transplant;

D O I：

10.1007/s11096-020-01195-x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient.

引用

页码：753 / 755

页数：3

共 50 条

[41] Treating comorbidity in solid organ transplant recipients as a confounder or a mediator of patient outcomes
Tanaka, Tomohiro
Vander Weg, Mark
Jones, Michael
Axelrod, David
AMERICAN JOURNAL OF TRANSPLANTATION, 2022,
[42] Chronic hepatitis associated with Hepatitis E virus in organ transplant patients
Pillet, S.
VIROLOGIE, 2008, 12 (02) : 142 - 144
[43] Taming the Beast: Tailored Therapy for Hepatitis E in Organ Transplant Recipients
Kotton, Camille Nelson
TRANSPLANTATION, 2015, 99 (10) : 2020 - 2021
[44] Prevalence and Incidence of Hepatitis E in Organ Waitlist and Transplant Recipients in the US
Samala, Niharika R.
Auh, Sungyoung
Abdullah, Karabala
Dakhoul, Lara
Johnson, Jessica
Wright, Elizabeth C.
Alter, Harvey J.
Lucey, Michael R.
Ghabril, Marwan S.
Rangnekar, Amol S.
Reddy, K. Rajender
Ghany, Marc G.
HEPATOLOGY, 2018, 68 : 710A - 711A
[45] Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
Low, En Xian Sarah
Tripon, Edhel
Lim, Kieron
Tan, Poh Seng
Low, How Cheng
Dan, Yock Young
Lee, Yin Mei
Muthiah, Mark
Loo, Wai Mun
Koh, Calvin Jianyi
Phyo, Wah Wah
Pang, JunXiong
Lim, Seng Gee
Lee, Guan-Huei
WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (06) : 553 - 561
[46] Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
En Xian Sarah Low
Edhel Tripon
Kieron Lim
Poh Seng Tan
How Cheng Low
Yock Young Dan
Yin Mei Lee
Mark Muthiah
Wai Mun Loo
Calvin Jianyi Koh
Wah Wah Phyo
JunXiong Pang
Seng Gee Lim
Guan-Huei Lee
World Journal of Hepatology, 2019, (06) : 553 - 561
[47] Hepatitis E viral infection in solid organ transplant patients
Fang, Stanley Y.
Han, Hyosun
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2017, 22 (04) : 351 - 355
[48] Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations
Zhang, Xiao
Lin, Guigao
Tan, Liming
Li, Jinming
BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 107 - 114
[49] Chronic hepatitis E after solid organ transplantation
de Niet, A.
Zaaijer, H. L.
ten Berge, I.
Weegink, C. J.
Reesink, H. W.
Beuers, U.
NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (06): : 261 - 266
[50] Characteristics of Post Transplantation Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center
Sue, Paul K.
Pisanic, Nora
Heaney, Christopher D.
Nelson, Kenrad
Schwarz, Kathleen B.
Valsamakis, Alexandra
Forman, Michael
Jackson, Annette M.
Ticehurst, John R.
Montgomery, Robert A.
Karnsakul, Wikrom
HEPATOLOGY, 2014, 60 : 535A - 535A

← 1 2 3 4 5 →